A Study of Bortezomib With Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia.
Phase of Trial: Phase I/II
Latest Information Update: 02 Jul 2012
At a glance
- Drugs Bortezomib (Primary) ; Cytarabine; Dexamethasone; Dexamethasone; Doxorubicin; Methotrexate; Pegaspargase; Vincristine
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 18 May 2012 Actual patient number 31 added as reported by ClinicalTrials.gov.
- 14 Dec 2011 Status changed from recruiting to completed.
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.